This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What will cosmetic patients seek in Spring 2025? To find out, RealSelf tapped 17 plastic surgeons, dermatologists, and other providers across the U.S. and culled insights from more than 55 million site visits. Published in the Companys quarterly Real Talk report, the top 5 cosmetic treatment trends of Spring 2025 will be: Surgical Facial Optimization: Facelifts will be the most popular this spring.
Red light is everywhere – you’ll see it used by celebrities, skincare influencers, and biohackers (not sure why male wellness influencers get their own special name). What does it do, and which products actually work? Let’s dig into the science behind red light therapy, or photobiomodulation. The video version of this post was part of a 3-way collaboration with Becky.
It's Day 1 of our 2025 SALON TODAY 200 announcements and we're cheering for the salons who excel at innovative strategies to attract new guests and retain existing ones, and for the salons who green their business practices to benefit the Earth, including Head Case Hair Studio in Keller, Texas.
Eli Lilly and Company is launching 7.5mg and 10mg Zepbound (tirzepatide) single-dose vials, available for$499with the new Zepbound Self Pay Journey Program. Lilly also reduced the price of the 2.5mg and 5mg vials. These new offerings are available exclusively through LillyDirect Self Pay Pharmacy Solutions, which enables a transparent price by removing third-party supply chain entities and allowing patients to access savings directly outside of insurance.
The U.S. Food and Drug Administration (FDA) has granted clearance for NovelMed Therapeutics ruxoprubart (NM8074), an investigational drug, to begin an efficacy Phase II trial to treatdermatomyositis (DM). This announcement follows the successful completion of a Phase I clinical trial involving 40 healthy volunteers, where ruxoprubart demonstrated promising results and a clean safety profile, with no serious adverse events reported.
Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed consistent safety and efficacy in patients with in moderate-to-severe plaque psoriasis for up to five years, new research shows. In patients who were treated continuously with deucravacitinib, clinical response rates were maintained from Year 1 to Year 5, including Psoriasis Area and Severity Index (PASI) 75, PASI 90 and static Physicians Global Assessment (sPGA) 0/1 (clear/almost clear).
Pioneering bond-building brand redefines hair health with a new brand identity, groundbreaking innovation in scalp and a commitment to empowering stylists worldwide.
At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a female patient aged 12 years with moderate AD that had been worsening over the past several months.
Researchers reported that propranolol initiation for infantile hemangiomas in pediatric patients is safe, with no significant complications, suggesting reduced need for intensive monitoring.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
58 
Let's personalize your content